Activities

• 

  Mary Grace Tamio   shared news

  on June 09 2025 at 11:00 PM Edited public

  Efficacy and safety of tenapanor vs placebo in treating CKD patients on dialysis and with hyperphosphatemia: a systematic review and meta-analysis of 2251 patients
  
  #CKD #dialysis #hyperphosphatemia #journals #articles
  
  More info | ⬇️

  

  Efficacy and safety of tenapanor vs placebo in treating CKD patients on dialysis and with hyperphosphatemia: a systematic review and meta-analysis of 2251 patients

  Hyperphosphatemia is common in chronic kidney disease (CKD) patients, especially patients on hemodialysis. Tenapanor is a ...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share